Will CCL complete its DLC unification (single NYSE listing) by end of Q2 calendar 2026?

Management publicly committed to Q2 2026 completion with shareholder votes in April 2026. Chairman Arison (controlling shareholder, 13.4M+ shares) supports unification, effectively guaranteeing the shareholder vote passes. This has been discussed for years and management has now taken concrete action. The only realistic failure scenario is regulatory delay, not shareholder rejection. UK FCA and Panama regulatory approvals are needed but are procedural for a legitimate corporate simplification. Probability above 80%.

The DLC unification is management-initiated, board-approved, and controlling-shareholder-supported. The question is timing, not outcome. 'By end of Q2 calendar 2026' means by June 30. With shareholder votes in April and regulatory approvals in parallel, the timeline is tight but achievable. The slight discount from certainty reflects: (1) multi-jurisdiction regulatory complexity, (2) potential for UK court approvals to take longer than expected, and (3) minor risk of plc minority shareholder opposition on exchange ratio terms.

Corporate actions with controlling shareholder support rarely fail on votes. The risk is timing — regulatory approvals across SEC, FCA, and Panama require coordination. Management's stated timeline of Q2 2026 with April votes suggests they've already engaged regulators and expect favorable timelines. However, 'completing' the unification (deregistration of plc shares, NYSE single listing) involves multiple steps that must complete by June 30. Any procedural delay pushes to Q3. Probability 80%.

DLC unification with controlling shareholder support and board approval has very high probability of completion. The only question is whether it happens by June 30 vs slipping to Q3. Corporate restructurings involving multiple jurisdictions often experience minor delays. Management's Q2 target is ambitious but the simplification benefits (reduced admin costs, improved index inclusion) create strong incentive. Probability high 70s.

I weight the timing risk more heavily. DLC unifications require: shareholder votes (2 separate entities), regulatory approvals (SEC, FCA), court approvals (UK scheme of arrangement), exchange ratio finalization, and deregistration. With April votes, that leaves only 2-3 months to complete post-vote steps. Historical DLC unifications (BHP, Unilever) took longer than initially planned. Probability 75% — likely to complete eventually but Q2 deadline is tight.

The fundamental question is timing. Management set Q2 2026 target publicly — missing it would be embarrassing and would undermine governance credibility. With Arison support and no obvious opposition, the biggest risk is regulatory processing time. Management likely would not have announced the Q2 target without advance regulatory engagement confirming feasibility. Probability high 70s.

Controlling shareholder supports. Board approves. Votes in April. Management publicly committed to Q2. Very high probability. Small discount for procedural delays. ~80%.

High probability of completion but Q2 deadline is tight for multi-jurisdiction restructuring. DLC unifications historically take longer than planned. Probability mid-70s reflecting timing risk.

Management announced with April vote date — suggests regulatory pre-clearance. Arison family controls vote outcome. Benefits are clear. Main risk is procedural timing. Probability ~78%.